Skip to main content
Smart Investors Daily
NI

OTC · NIKA

Nika Pharmaceuticals Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

$0.41

Up+$0.00 (+0.00%)

Updated Oct 12, 2026, 10:53 AM

SID Score

4.0/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
270.36M
P/E ratio
-5,117.66
Dividend yield
0.00%
52-week range
— – —
Volume
22
Avg. volume
829

Price performance · NIKA

NIKA price history

1M range · 0 trading sessions · Daily adjusted prices

NIKA does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest NIKA news

The latest Smart Investors Daily articles mentioning NIKA.

NIKA research

Overview

Company profile and research snapshot.

Company profile

NIKA PHARMACEUTICALS INC

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
Open full forecast

News briefing

No generated briefing is available yet.

globenewswire.com · Dec 3, 2025

Nika Pharmaceuticals, Inc. (NIKA) Progress Update

HENDERSON, Nev., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCQB: NIKA) appeared on The Street Reports podcast where CEO Dimitar Savov shared the progress the company has made thus far and outlined what is expected for 2026, which will be a crucial year for the company.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.